Inside Look At A Fruit Fly Biomanufacturing Facility | Future Fields Instar 1.0 Biofactory

Scaling protein production often introduces variability, process changes, and costly translation losses between research and manufacturing. An alternative approach uses transgenic Drosophila melanogaster as a living bioreactor, enabling protein expression and commercial-scale production under the same operating conditions from start to finish.

By maintaining identical processes across development stages, manufacturers can scale biomass from small research batches to production volumes with greater predictability and confidence. Harvested biomass can be frozen to preserve proteins in their native state, supporting flexible, on-demand manufacturing without unnecessary processing.

Quality remains central throughout the workflow. Downstream purification is compatible with industry-standard chromatography methods, while rigorous testing helps ensure purity, biological activity, and consistency from batch to batch. Learn how this manufacturing model delivers a more predictable path from protein expression to commercial production while maintaining the quality standards required for complex biologics.